“If there was medication to keep symptoms at bay, it would really help improve the quality of life for most of my patients.”

Patients & carers

Patients & carers

We are developing a drug aimed at reducing one of the core symptoms of autism.
See what we have accomplished

Medical professionals

Health Professionals

Our lead drug candidate for autism is now at phase III of clinical development.
Find out more about the autism program.

Investors

Investors

For all key financial information including share price performance, visit our Investors section.